FDA, European Agencies Working On "Scientific Advice" Cooperation
This article was originally published in The Pink Sheet Daily
Collaboration with FDA on regulatory science guidelines is a "priority" for 2004, EMEA’s Lonngren tells DIA EuroMeeting in Prague. Details on specific areas and procedures for cooperation could be ready by the end of the summer.
You may also be interested in...
Senior VP-Global Clinical & Pharmaceutical Development Elliott Sigal is acting president of Bristol-Myers Squibb’s research institute following the death of James Palmer.
The four-pronged plan will address “bio-burden,” manufacturing techniques, quality systems and execution, CEO Pien says. Chiron has met twice with U.K. authorities and hopes to realize similar progress with FDA soon.
The company is talking with oncologists about Aranesp ahead of a switch in Medicare reimbursement in January 2005. U.S. sales for the red blood cell product were up 32% in the third quarter.